Healthcare services startup Sanitas wins FDA clearance for its Wellaho mobile and web platform as a HIPAA-compliant medium for monitoring patients between visits.
California mobile health services company Sanitas won FDA clearance for its Wellaho system, a proprietary mobile and online platform providing a link between patients and healthcare providers.
The Wellaho platform is "an outpatient management system for chronically ill patients," according to the company's website.
The device helps patients access their health records and monitor various health indicators, including weight, blood glucose levels, blood pressure and others.
On the other end of the app, doctors can use the Wellaho system to monitor patients' health between visits in a secure, HIPAA-compliant medium.
"Given the tsunami of new apps and technologies that hit the market each year, both patients and providers need the highest validation for the products and services they use," Sanitas CEO Naser Partovi said in prepared remarks. "Now, with the FDA's approval, Wellaho offers 1 more reason for providers and patients to trust that we can provide a safe, secure, and effective solution for managing their care."
Here's a look at some of the top funding stories for medical device companies this week.
FDA officials warn against the use of "laparoscopic power morcellation" for the removal of uterine...
Bio-artificial liver maker Vital Therapies takes its IPO even lower, now planning to open at $12 per...
California surgical devices maker Cardica details a public offering of common and preferred stock...